Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multi-metastatic Cancer”

1,735 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,735 results

Early research (Phase 1)Not Yet RecruitingNCT07057349
What this trial is testing

CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer

Who this might be right for
Metastatic CancerUnresectable Solid Tumor
Cytosite Biopharma Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06662006
What this trial is testing

Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer Patients

Who this might be right for
Advanced Metastatic Pancreatic Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 56
Not applicableEnded earlyNCT00253552
What this trial is testing

G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
OHSU Knight Cancer Institute 4
Testing effectiveness (Phase 2)Ended earlyNCT06516926
What this trial is testing

SHR-4602 for Injection in Subjects With HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors

Who this might be right for
HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors
Jiangsu HengRui Medicine Co., Ltd. 11
Testing effectiveness (Phase 2)Looking for participantsNCT05970497
What this trial is testing

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Who this might be right for
CancerMelanoma Stage IIIMelanoma Stage IV+1 more
Krystal Biotech, Inc. 240
Early research (Phase 1)UnknownNCT03282825
What this trial is testing

Clinical Study of Decitabine and Paclitaxel Combination Therapy

Who this might be right for
Advanced Breast Cancer
Dong Wha Pharmaceutical Co. Ltd. 18
Testing effectiveness (Phase 2)Looking for participantsNCT05803018
What this trial is testing

BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies

Who this might be right for
Gynecological Malignant TumorSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 38
Early research (Phase 1)Study completedNCT00532090
What this trial is testing

A Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors.

Who this might be right for
Neoplasms
Hoffmann-La Roche 110
Early research (Phase 1)UnknownNCT03310008
What this trial is testing

Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases

Who this might be right for
Colon Cancer Liver Metastasis
Celyad Oncology SA 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT02886585
What this trial is testing

Pembrolizumab In Central Nervous System Metastases

Who this might be right for
Brain Metastases
Massachusetts General Hospital 101
Testing effectiveness (Phase 2)Looking for participantsNCT07789210
What this trial is testing

A Single-Arm, Phase II, Multicenter Clinical Study of Neoadjuvant Encorafenib Plus Cetuximab N01 and mFOLFOX6 in Patients With Locally Advanced BRAF V600E-Mutant Colorectal Cancer With or Without Resectable Metastases

Who this might be right for
Colorectal CancerBRAF V600E Mutation PositiveEncorafenib+1 more
Zhejiang University 25
Not applicableEnded earlyNCT00608517
What this trial is testing

Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Vanderbilt-Ingram Cancer Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT07336446
What this trial is testing

A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs

Who this might be right for
Prostate Cancer
AstraZeneca 300
Testing effectiveness (Phase 2)Looking for participantsNCT06802835
What this trial is testing

EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Recurrent Nasopharynx CarcinomaMetastatic Nasopharyngeal Carcinoma
Sun Yat-sen University 148
Testing effectiveness (Phase 2)Looking for participantsNCT06222879
What this trial is testing

Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Shandong Suncadia Medicine Co., Ltd. 350
Testing effectiveness (Phase 2)Study completedNCT00300950
What this trial is testing

Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer

Who this might be right for
Pancreas Cancer
GlobeImmune 176
Testing effectiveness (Phase 2)Study completedNCT03558191
What this trial is testing

SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy.

Who this might be right for
Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 156
Large-scale testing (Phase 3)Study completedNCT03764293
What this trial is testing

Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC

Who this might be right for
Locally Advanced or Metastatic and Unresectable HCC
Jiangsu HengRui Medicine Co., Ltd. 543
Testing effectiveness (Phase 2)Active Not RecruitingNCT03787680
What this trial is testing

Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 49
Large-scale testing (Phase 3)Study completedNCT01360853
What this trial is testing

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Traws Pharma, Inc. 160
Next Page